New York, Jan 7, 2026, 17:15 EST — After-hours
UnitedHealth Group Inc (UNH) shares fell about 2% to $341.70 in after-hours trading on Wednesday, after sliding through the close. The stock ranged from $338.11 to $349.55 during the session, leaving traders watching whether the late-day low holds into Thursday.
The pullback comes as investors look for signs the company is trimming edges ahead of its next guidance. Sky News reported on Tuesday that private equity firm TPG is close to buying Optum UK for between 1.2 billion pounds and 1.4 billion pounds ($1.62 billion to $1.89 billion), with Bank of America advising on the process. Optum UK supplies electronic patient record systems to most British general practitioners, the report said, adding the talks could still fall apart.
UnitedHealth had climbed about 3% on Tuesday, one of the biggest boosts to the Dow, before giving some of that back as the index weakened on Wednesday. With the Jan. 27 report nearing, the market is trying to pin down a simpler question: are medical costs easing, and can Optum’s margins stabilize enough for a cleaner 2026 outlook.
Analyst notes have leaned more constructive into the earnings setup. Barclays analyst Andrew Mok on Monday raised his price target on UnitedHealth to $391 from $386 and kept an “overweight” rating, meaning he expects the shares to outperform the average in his coverage. Mok said managed-care names — health insurers that manage costs through contracted provider networks — could benefit in 2026 from margin expansion and a rotation toward “de-rated underperformers.” TipRanks
Peers moved in the same direction on Wednesday, keeping the sector tone heavy. Cigna slipped about 2% and CVS Health and Elevance Health also fell as the broader market ended lower.
UnitedHealth will release full-year 2025 results and provide 2026 financial guidance on Tuesday, Jan. 27, before the market opens, and will host a conference call at 8 a.m. ET, the company said. Investors typically focus on the medical care ratio — the share of premiums spent on medical claims — along with Optum’s service margins and any detail on pricing and cost controls.
Macro data also tightened risk appetite late in the day. U.S. job openings fell to a 14-month low in November, and an ADP report showed private hiring rose modestly in December; “jobs were gained in December, but at a relatively slow pace,” High Frequency Economics chief economist Carl Weinberg said. Reuters
But the bigger swing factor for UnitedHealth is still utilization. If doctor and hospital visits stay elevated, management’s 2026 outlook could land soft, and a potential Optum UK deal would not change that quickly.
Next up, traders get U.S. productivity data on Thursday, the December jobs report on Friday and December CPI on Jan. 13 — all inputs for rate expectations before UnitedHealth reports. The Federal Reserve meets Jan. 27-28, the same week UnitedHealth is set to lay out its 2026 guidance.
